Cobalt sulfate is a water-soluble cobalt salt with a variety of industrial and agricultural uses. Several cobalt compounds have induced sarcomas at injection sites in animals, and reports have suggested that exposure to cobalt-containing materials may cause lung cancer in humans. The present studies were done because no adequate rodent carcinogenicity studies had been performed with a soluble cobalt salt using a route relevant to occupational exposures. Groups of 50 male and 50 female F344/N rats and B6C3F 1 mice were exposed to aerosols containing 0, 0.3, 1.0, or 3.0 mg/m 3 cobalt sulfate hexahydrate, 6 h/day, 5 days/week, for 104 weeks. Survival and body weights of exposed rats and mice were generally unaffected by the exposures. In rats, proteinosis, alveolar epithelial metaplasia, granulomatous alveolar inflammation, and interstitial fibrosis were observed in the lung in all exposed groups. Nonneoplastic lesions of the nose and larynx were also attributed to exposure to all concentrations of cobalt sulfate. In 3.0 mg/m 3 male rats and in female rats exposed to 1.0 or 3.0 mg/m 3 , the incidences of alveolar/bronchiolar neoplasms were increased over those in the control groups. Lung tumors occurred with significant positive trends in both sexes. The incidences of adrenal pheochromocytoma in 1.0 mg/m 3 male rats and in 3.0 mg/m 3 female rats were increased. Nonneoplastic lesions of the respiratory tract were less severe in mice than in rats. In mice, alveolar/bronchiolar neoplasms in 3.0 mg/m 3 males and females were greater than those in the controls, and lung tumors occurred with significantly positive trends. Male mice had liver lesions consistent with a Helicobacter hepaticus infection. Incidences of liver hemangiosarcomas were increased in exposed groups of male mice; however, because of the infection, no conclusion could be reached concerning an association between liver hemangiosarcomas and cobalt sulfate. In summary, exposure to cobalt sulfate by inhalation resulted in increased incidence of alveolar/bronchiolar neoplasms and a spectrum of inflammatory, fibrotic, and proliferative lesions in the respiratory tracts of male and female rats and mice. Adrenal pheochromocytomas were increased in female rats, and possibly in male rats.
Over 1 million U.S. workers are exposed to cobalt or cobalt compounds (Jensen and Tüchsen, 1990) . Exposure occurs primarily in industrial refining, in the production of alloys, and in the tungsten carbide hard metal industry (Kazantzis, 1981) . The route of exposure is frequently dermal or via inhalation of cobalt metal dusts or fumes, often in combination with nickel, arsenic, or tungsten. Adverse respiratory effects (pneumoconiosis) have been reported at cobalt concentrations between 0.1 and 2 mg/m 3 (Domingo, 1989) . Cobalt sulfate is used in the electroplating and electrochemical industries, as a coloring agent for ceramics, as a drying agent in inks, paints, varnishes, and linoleum, and as a mineral supplement for pasture lands (De Bie and Doyen, 1962) .
Exposure to cobalt results in a wide spectrum of toxicities. Cobalt can mimic or replace Mg 2ϩ , Ca 2ϩ and other ions in many reactions (Jennette, 1981) ; it binds to sulfhydryls (Dingle et al., 1962) , inhibits heme synthesis in the liver (De Matteis and Gibb, 1977) and also induces heme oxygenase (Maines and Kappas, 1976) , with the combined effect of rapidly decreasing cytochrome P 450 concentrations. Other cytochromes are less affected (Tephly and Hibbeln, 1971) . Cobalt also causes polycythemia (Murdock, 1959) .
Various cobalt dusts and aerosols have been administered to animals via inhalation. Lung compliance is decreased and electrical properties of the heart are affected (Kerfoot et al., 1975) . In addition, specific pulmonary effects in male rabbits exposed to 0.5 mg/m 3 cobalt chloride for 4 to 6 weeks included an altered growth pattern of alveolar type II cells, and changes in oxidative metabolism of lung macrophages (Johansson et al., 1984 (Johansson et al., , 1986 .
Thirteen-week inhalation studies with cobalt sulfate in F344/N rats and B6C3F 1 mice have been reported (Bucher et al., 1990; NTP, 1991) . In 13-week studies, rats and mice were exposed to cobalt sulfate hexahydrate concentrations ranging from 0.3 to 30 mg/m 3 , 6 h/day, 5 days per week. Two of 10 male mice exposed to 30 mg/m 3 died. All groups at this concentration initially lost weight, but then gained weight at rates similar to controls. At the end of the studies, lung weights were generally increased in rats and mice exposed to 1.0 mg/m 3 and higher, and polycythemia was observed in exposed rats but not in mice. Lesions observed in the respiratory tracts of rats and mice included degeneration of the olfactory epithelium, squamous metaplasia of the respiratory epithelium, and inflammation. Inflammation, necrosis, squamous metaplasia, ulcers (rats), and inflammatory polyps (rats) were seen in the larynx. Squamous metaplasia of the trachea was observed in mice, and histiocytic infiltrates, bronchiolar regeneration, peribronchiolar and septal fibrosis, and alveolar epithelial hyperplasia of the lung were also seen in rats and mice. A noobserved-adverse-effect-level (NOAEL) was not reached in these studies, as lesions, particularly in the larynx, were observed at the lowest exposure (0.3 mg/m 3 ) used. There have been no reports of adequate chronic inhalation toxicity or carcinogenicity studies with soluble or insoluble cobalt salts or metal powders (IARC, 1991) . Wehner et al. (1977) found no increase in tumors in Syrian golden hamsters exposed to 10 mg/m 3 cobalt oxide dust for 7 h/day, 5 days per week, for life; however, the study was faulted for poor survival (IARC, 1991) . Cobalt oxide has been studied by intratracheal administration to Sprague-Dawley rats (Steinhoff and Mohr, 1991) . Doses of 2 or 10 mg/kg were given for 19 treatments at 2-week intervals and for 10 treatments at 4-week intervals over 2 years. At the end of the study, bronchioalveolar proliferation was noted at high rates in exposed rats, and in no controls. One male and one female from the low-dose groups had a benign lung tumor, and one high-dose female had a bronchioalveolar carcinoma. Three adenocarcinomas and two bronchioalveolar adenomas were observed in high-dose males. No lung tumors occurred in the controls.
Sarcomas in rats have been observed at the site of injection of cobalt salts (including one study with a soluble salt) or cobalt metal powder (IARC, 1991) . Similar injection studies have given little evidence of cobalt-induced cancer in mice, hamsters, or guinea pigs (Christensen and Poulsen, 1994) .
In 1990 the IARC (1991) considered the available data inadequate to establish an association between cancer and cobalt exposure to humans. Two epidemiological studies were considered adequate for evaluation (Hogstedt and Alexandersson, 1990; Mur et al., 1987) . The Mur et al. (1987) cohort study was composed of 1,143 workers who were employed for at least a year between 1950 and 1980 in a French electrochemical plant. For workers employed only in cobalt production, an SMR for lung cancer was 4.66 (95% CI 1.46 to 10.64) based on 4 cases. Hogstedt and Alexandersson (1990) studied a cohort of 3,163 male Swedish workers with at least 1 year of exposure to cobalt-containing, hard-metal dust ore between 1940 and 1982. There were 17 cases of lung cancer versus 12.7 expected (SMR, 1.34; 95% CI 0.77 to 2.13). Interpretation of both studies was made difficult by concurrent exposures to other substances including arsenic and nickel in the French plant and tungsten carbide in the Swedish facility.
Since the IARC evaluation, the French electrochemical plant workers were followed through 1988. No additional lung cancers were observed. The authors concluded that the data no longer supported an association of cobalt exposure with lung cancer (Moulin et al., 1993) . In contrast, Lasfargues et al. (1994) reported a cohort mortality study carried out on workers at a French hard-metal plant. The study specifically addressed lung cancer risks in relation to cobalt exposure and included 709 male workers who had at least 1 year of employment at the plant and who died between the years 1956 and 1989. Overall mortality was not increased, but death due to lung cancer was significantly elevated (SMR, 2.13; 95% CI 1.02-3.93), with 10 cases observed and 4.7 expected. This excess was associated with high cobalt exposure, but duration of employment was not associated with an increased risk.
Cobalt sulfate was nominated to the National Toxicology Program for study by the National Cancer Institute, based on a need for more information on the carcinogenicity and toxicity in rodents of soluble cobalt salts. The more common cobalt(II) form and the inhalation route were selected to better mimic worker-exposure. Exposure concentrations selected for the 2-year studies were based on 13-week studies reported earlier (Bucher et al., 1990; NTP, 1991) .
MATERIALS AND METHODS
Cobalt sulfate heptahydrate was obtained from Curtin Matheson Scientific (Kansas City, MO) in one lot (412092). Identity and purity analyses, information on aerosol generation and monitoring, and chamber design and characterization were reported earlier (Bucher et al., 1990; NTP, 1998) . The exposures were generated as an aqueous aerosol, and were partially dried before entering the chambers. Analysis of chamber samples indicated the average particle was composed of 1 mole cobalt, 1 mole sulfate, and 5.9 mole water per mole of aerosolized cobalt sulfate, indicating that the exposures were to cobalt sulfate hexahydrate. Thus, the concentrations reported are of cobalt sulfate hexahydrate rather than to the anhydrous salt as reported earlier (Bucher et al., 1990) . Aerosol size distribution was determined monthly for each exposure chamber. The mass median aerodynamic diameter for the aerosol was within 1 to 3 m (NTP, 1998).
Groups of 50 male and 50 female F344/N rats and B6C3F1 mice were exposed to 0, 0.3, 1.0, or 3.0 mg/m 3 cobalt sulfate for 6 h plus T 90 (12 min) per day, 5 days per week, for 104 weeks. The exposure concentrations for the 2-year cobalt sulfate studies were based on the findings of 16-day and 13-week studies reported previously, with primary consideration given to the lesions in the larynx (Bucher et al., 1990; NTP, 1991) .
Rats and mice were obtained from Simonsen Laboratories (Gilroy, CA) at about 4 weeks of age and were quarantined for 14 days prior to the studies. The health of the animals was monitored prior to and during the studies according to the protocols of the NTP Sentinel Animal Program.
Rats and mice were housed individually. Feed (NIH 07 diet, Zeigler Bros. Inc., Gardners, PA) was available ad libitum except during exposure periods, and water was available ad libitum. Cage racks were rotated weekly. All animals were observed twice daily. Clinical findings and body weights were recorded initially, weekly for 13 weeks, monthly through week 92, and every 2 weeks thereafter.
A complete necropsy and microscopic examination was performed on each animal. At necropsy, all organs and tissues were examined for grossly visible lesions, and all major tissues were fixed and preserved in 10% neutral buffered formalin, trimmed and processed, embedded in paraffin, sectioned to a thickness of 5 to 6 m, and stained with hematoxylin and eosin. For all paired organs (i.e., adrenal gland, kidney, ovary), samples from each organ were examined. Details of the microscopic diagnoses, pathology data reviews and quality assurance procedures have been reported (NTP, 1998) .
The probability of survival was estimated by the product-limit procedure of Kaplan and Meier (1958) and is presented in the form of graphs. Animals found dead of other than natural causes were censored from the survival analyses. Statistical analyses for possible dose-related effects on survival used Cox's (1972) method for testing two groups for equality and Tarone's (1975) life table test to identify dose-related trends. All reported P values for the survival analyses are two-sided. The majority of neoplasms and nonneoplastic lesions in these studies were considered to be incidental to the cause of death or not rapidly lethal. Thus, the primary statistical method used was logistic regression analysis as described by Dinse and Haseman (1986) . Reported P values are one-sided. Average severity values were analyzed for significance using the Mann-Whitney U test (Hollander and Wolfe, 1973) . For further discussion of these statistical methods, refer to Haseman (1984) . The studies were conducted in compliance with Food and Drug Administration Good Laboratory Practice Regulations (21 CFR, Part 58), and appropriate NIH guidelines for the care and use of animals.
RESULTS

Rats
Survival, Body Weights, and Clinical Findings
Estimates of 2-year survival probabilities are shown in the Kaplan-Meier survival curves ( Fig. 1) . Survival of males (17/50 controls, 15/50 low exposure, 21/50 mid exposure, and 15/50 high exposure) and females (28/50, 25/50, 28/50, 30/50) and mean body weights of exposed rats were similar to those of the controls throughout the study (Fig. 2) . Irregular breathing was observed more frequently in female rats exposed to 3.0 mg/m 3 than in other groups.
Pathology and Statistical Analyses
Lung. In all exposed groups, the incidences of proteinosis, alveolar epithelial metaplasia, granulomatous inflammation, and interstitial fibrosis were significantly greater than those in the controls (Table 1) . Throughout the lungs, the architecture was distorted by a combination of inflammatory cells, fibrosis, and epithelial metaplasia. Lesions tended to be subpleural, peripheral, and/or along larger blood vessels and airways.
The incidences of alveolar epithelial hyperplasia in all groups of males and in females exposed to 3.0 mg/m 3 and atypical alveolar epithelial hyperplasia in 3.0-mg/m 3 females were significantly greater than those in the controls. The combined incidence of alveolar/bronchiolar neoplasms (adenoma and/or carcinoma) was significantly greater in 3.0-mg/m 3 males than that in the controls (Table 1) . In females exposed to 1.0 or 3.0 mg/m 3 , the incidences of alveolar/bronchiolar neoplasms were also increased and exceeded the historical control ranges (Table 1) . Although the incidences of alveolar/bronchiolar adenoma in 3.0-mg/m 3 males and alveolar/bronchiolar carcinoma in 1.0-mg/m 3 males were not significantly increased, they exceeded the historical control ranges for inhalation studies. Lung tumors occurred with significant positive trends in both sexes.
The spectrum of alveolar/bronchiolar neoplasms and nonneoplastic proliferative lesions observed within the lungs of exposed rats was broad. While many of these lesions were highly cellular and morphologically similar to those occurring spontaneously, others were predominantly fibrotic, squamous, or mixtures of alveolar/bronchiolar epithelium and squamous or fibrous components. "Fibroproliferative" lesions ranged from a few hundred m to greater than 1 cm in diameter. Generally, these lesions had a rounded outline and a central fibrous core containing dispersed glandular (alveolar) structures lined by uniformly cuboidal epithelial cells. Aggregates of mostly necrotic inflammatory cells were also present in adjacent alveoli and often within the glandular structures. Peripherally, the fibroproliferative lesions had one to several layers of epithelium, which coursed along and often extended into adjacent alveoli, frequently forming papillary projections. These epithelial cells were slightly pleomorphic with occasional mitotic figures. The smallest of these lesions were usually observed adjacent to areas of chronic inflammation. Small lesions with modest amounts of peripheral epithelial proliferation were diagnosed as atypical hyperplasia (Figures 3, 4 , and 5), while larger lesions with florid epithelial proliferation, FIG. 1. Kaplan-Meier survival curves for rats exposed to cobalt sulfate by inhalation for 2 years. marked cellular pleomorphism, and/or local invasion were diagnosed as alveolar/bronchiolar carcinomas ( Figure 6 ).
While squamous epithelium is not normally observed within the lung, squamous metaplasia of alveolar/bronchiolar epithelium is a relatively common responset to pulmonary injury and occurred in a number of rats in this study (Table 1) . One 3.0-mg/m 3 male and one 1.0-mg/m 3 female each had 1 large cystic squamous lesion rimmed by a variably thick band of viable squamous epithelium with a large central core of keratin ( Figure 7 ). These were diagnosed as cysts. In one 1.0-mg/m 3 and one 3.0-mg/m 3 female, proliferative squamous lesions had cystic areas but also more solid areas of pleomorphic cells and invasion into the adjacent lung; these lesions were considered to be squamous cell carcinomas. In general, diagnoses of squamous lesions were made only when the lesion composition was almost entirely squamous epithelium. However, squamous metaplasia/differentiation was a variable component of other alveolar/bronchiolar proliferative lesions (Figure 8 ), including the fibroproliferative lesions, and was clearly a part of the spectrum of lesions resulting from exposure to cobalt sulfate.
Adrenal Medulla. In females, benign pheochromocytoma occurred with a positive trend. The incidence in 3.0-mg/m 3 females was significantly greater than that in the controls and exceeded the historical range for inhalation studies ( Table 2 ). The incidence of benign, complex, or malignant pheochromocytoma (combined) in 1.0 mg/m 3 males and in 3.0 mg/m 3 females were significantly greater than those in the controls and also exceeded the historical control ranges ( Table 2 ). The incidence of hyperplasia were not increased in exposed males or females. Although a common spontaneous neoplasm in male F344/N rats, pheochromocytomas have a much lower occurrence in females. In this study, the incidence of pheochromocytoma in 3.0-mg/m 3 females was considered exposure-related. The marginal increase in pheochromocytoma in males was considered an uncertain finding because it occurred only in the 1.0-mg/m 3 group and was not supported by increased hyperplasia.
Nose. The incidence of hyperplasia of the respiratory epithelium of the lateral wall of the nose and atrophy of the olfactory epithelium in all exposed groups was significantly greater than in the controls, and the severity of these lesions increased with increasing exposure concentration ( Table 3) . The incidence of squamous metaplasia of the respiratory epithelium of the lateral wall of the nose and metaplasia of the olfactory epithelium in 3.0-mg/m 3 groups was increased over that in the controls. The lesions involved limited portions of nasal epithelium and the severity was mild to moderate.
Larynx. The incidence of squamous metaplasia of the epiglottis in all exposed groups was significantly greater than those in the controls, and the severity of this lesion increased with increasing exposure concentration (Table 3) . Squamous metaplasia was limited to the base of the epiglottis and was minimal to mild in severity.
Mice
Survival, Body Weights, and Clinical Findings
Estimates of 2-year survival probabilities are shown in the Kaplan-Meier survival curves (Fig. 9) . Survival of males (22/50 controls, 31/50 low-exposure, 24/50 mid-exposure, and 20/50 high-exposure) and females (34/50, 37/50, 32/50, 28/50) was similar in exposed groups and controls. Mean body weights (Fig. 10 ) of 3.0-mg/m 3 males were similar to those of the controls until week 96. The mean body weights of all exposed females were generally greater than of the chamber controls. Irregular breathing was observed more frequently in female mice exposed to 3.0 mg/m 3 than in other groups.
Pathology and Statistical Analyses
Lung. In all exposed groups, the incidence of cytoplasmic vacuolization of the bronchi was significantly greater than in FIG. 2. Growth curves for rats exposed to cobalt sulfate by inhalation for 2 years. the controls (Table 4 ). The incidence of diffuse histiocytic cell infiltration in 3.0-mg/m 3 males and of focal histiocytic cell infiltration in 3.0-mg/m 3 females was increased. Histiocyte infiltrate was commonly seen in lungs with alveolar/bronchiolar neoplasms, and was considered a consequence of the higher incidence of lung neoplasms rather than a primary effect of cobalt sulfate.
The incidence of alveolar/bronchiolar neoplasms (adenoma and carcinoma combined) in 3.0-mg/m 3 groups and the combined incidence of alveolar/bronchiolar neoplasms in 1.0-mg/m 3 females was significantly greater than in the controls and generally exceeded the historical control ranges (Table 4) . The incidence of pulmonary neoplasms occurred with positive trends. Unlike in the rat, the alveolar/bronchiolar proliferative lesions in exposed mice were typical of those occurring spontaneously.
Nose. The incidence of atrophy of the olfactory epithelium in 1.0-and 3.0-mg/m 3 groups and hyperplasia of the olfactory epithelium in 3.0-mg/m 3 groups was significantly greater than in the controls. The incidences of suppurative inflammation in 3.0-mg/m 3 males and in 1.0-mg/m 3 females were also increased (Table 5 ). Nasal lesions in mice were less severe than in rats and involved limited segments of the olfactory epithelium located further back in the nasal passage. Suppurative inflammation was mild and was seen in a few animals that died early.
Larynx. The incidence of squamous metaplasia in all exposed groups was significantly greater than in the controls (Table 5) . Squamous metaplasia was limited to the base of the epiglottis and was not a severe lesion.
Liver. Chronic inflammation, karyomegaly, oval cell hyperplasia, and regeneration occurred in all groups of male mice and were usually observed together (Table 6 ). Similar lesions were observed in only a few females, and the severity was much less than in males. This observation is consistent with a Helicobacter hepaticus infection. Liver sections from 4 of 5 male mice with hepatic lesions were positive for bacterial organisms resembling Helicobacter when examined using Steiner's modification of the Warthin Starry silver stain. The incidence of hepatic neoplasms in males exceeded the historical control range. The incidence of hemangiosarcoma in 1.0-mg/m 3 males was significantly greater than that in the controls (Table 6) , and the incidence in all exposed groups exceeded the 
FIG. 5.
High magnification of the border of an atypical hyperplasia in the lung of a male F344/N rat exposed to 3.0 mg/m 3 cobalt sulfate by inhalation for 2 years. Note the necrotic debris within the glandular structure (arrows) and the proliferative epithelium at the periphery (curved arrows). H and E; magnification, ϫ87.
FIG. 6.
Alveolar/bronchiolar carcinoma with abundant fibrous connective tissue (arrows) in the lung of a male F344/N rat exposed to 1.0 mg/m 3 cobalt sulfate by inhalation for 2 years. H and E; magnification ϫ12.
FIG. 7.
Squamous metaplasia along the alveolar wall consisting of several layers of squamous epithelium (arrows) in the lung of a female F344/N rat exposed to 3.0 mg/m 3 cobalt sulfate by inhalation for 2 years. H and E; magnification ϫ112. historical range. Hemangiosarcomas were morphologically similar to those occurring spontaneously.
DISCUSSION
This report presents the findings of 2-year inhalation studies with cobalt sulfate. An earlier report (Bucher et al., 1990; NTP, 1991) discussed 16-day and 13-week inhalation studies conducted prior to the 2-year studies at the same laboratory. In all studies, the respiratory tract was the primary site of nonneoplastic lesions and neoplasms. In the 13-week studies, laryngeal lesions ranged from mild squamous metaplasia, with or without chronic inflammation, at concentrations ultimately selected for the 2-year studies, to large inflammatory polyps present in rats exposed to higher concentrations. Although other respiratory tract lesions were present, the larynx was the most sensitive to cobalt sulfate, and lesions in this tissue were the determining factor in exposure concentration selection for the 2-year studies.
The highest concentration (3.0 mg/m 3 ) chosen for the 2-year studies did not affect survival or body weight gains of rats or survival of mice in either the 13-week or 2-year studies. Polycythemia noted in rats in the 13-week study was minimal at 3.0 mg/m 3 , and there was no indication that this effect worsened to the point of causing clinical findings with longer exposure, although no hematologic measures were performed during the 2-year study. Similarly, there was no indication that the lesions observed in rats and mice in the 13-week studies in the larynx progressed in extent or changed in character with prolonged exposures. There was no evidence of laryngeal polyp formation in rats, and the metaplastic and inflammatory changes in rats were greater than in mice.
In contrast to the findings in the larynx, prolonged exposure to cobalt sulfate caused progressive injury to the nose of rats and mice and to the lung of rats. Olfactory epithelial degeneration occurred primarily in rats and mice exposed to 10 and 30 mg/m 3 in the 13-week studies, but olfactory epithelial atrophy was increased at even the lowest concentration (0.3 mg/m 3 ) in rats and at 1.0 mg/m 3 in mice in the 2-year studies. Lesions in the lungs of rats changed markedly in character with the prolonged exposure in the 2-year study. Inflammation in the alveoli of rats was more severe and occurred at lower concentrations than in the prechronic studies, and alveoli proteinosis was moderate to marked in the 2-year study and not noted in the prechronic study. Interstitial fibrosis is known to be a relatively slowly developing lesion in the lung, but the extent of this lesion and its occurrence in essentially all rats at all exposure concentrations was not predicted based on the findings of the 13-week study. The alveolar epithelium of rats also displayed a spectrum of proliferative changes ranging from metaplasia through hyperplasia and atypical hyperplasia, and extending to neoplasia. The spectrum of proliferative pulmonary lesions observed in rats ranged from highly cellular proliferations (typical of spontaneous lesions) to fibroproliferative and squamous lesions (atypical lesions). The biological behavior of "typical" lung lesions, and to a lesser extent, squamous lesions, is fairly well documented. However, little is known about the biology of fibroproliferative lesions. In this study, many of the smaller fibroproliferative lesions were identified within and/or adjacent to areas of chronic inflammation and fibrosis; however, these lesions represented proliferative lesions distinct from inflammation. Based upon the morphological spectrum observed, it appears that their growth is progressive. There was, however, no morphological correlate signaling autonomy of growth (i.e., consistent with a benign neoplasm) for these fibroproliferative lesions. Therefore, unless growth alterations consistent with a malignant neoplasm were present, all fibroproliferative lesions were diagnosed as atypical hyperplasia. There were several animals with malignant neoplasms having prominent fibrous components; presumably, some of these progressed from atypical hyperplasias. In many respects, the range of proliferative lesions within the lungs of exposed rats resembled those observed in NTP studies of particulates (talc and the nickel compounds; NTP, 1993 NTP, , 1996a NTP, , 1996b NTP, , 1996c , and it is clear that all the morphological variants of proliferative lesions represent a response to cobalt sulfate.
Nonneoplastic lesions in the lungs of exposed mice did not differ appreciably from those expected in mice, based on the results of the prechronic study. The lesions were confined primarily to histiocytic infiltration, and there was an absence of fibrosis and only minimal evidence of the nonneoplastic proliferative lesions noted in exposed rats. Histiocytic infiltration was probably secondary to the presence of pulmonary neoplasms and is not necessarily related to exposure to cobalt sulfate. Nonetheless, the pulmonary changes were much less severe than those seen in rats and differed markedly in character.
While rats and mice exhibited different nonneoplastic pulmonary responses to cobalt sulfate, all exposed groups developed alveolar/bronchiolar adenomas and carcinomas. The magnitude of the neoplastic response was somewhat less in male rats than in the other groups.
Pheochromocytomas of the adrenal medulla were increased in female rats exposed to cobalt sulfate. While the incidence of this neoplasm was increased in exposed males and females, the strength of the response was greater in females, and the increase in males was judged equivocal. In the NTP database of studies of nearly 450 chemicals, pheochromocytomas were part of a carcinogenic response in only 13 rat studies, and five of these were inhalation studies. The historical control rates of pheochromocytomas do not appreciably differ between inhalation and feed studies, but a positive response is more likely to occur in inhalation studies than in studies using other routes of exposure. The reasons for this are not clear.
A number of factors need to be considered to properly address the relationship of these findings to typical human exposures to cobalt. The highest potential exposure to significant airborne cobalt concentrations is to workers in the hard metal industries, coal mining, and those involved in ore processing (USDHHS, 1992) . In these situations, cobalt may exist in various forms, primarily as cobalt powder or cobalt oxide. These agents are less soluble than cobalt sulfate, and the toxic response of the respiratory system would likely depend on the combination of inherent toxicity, solubility in biological fluids, and residence time in the tissue. The carcinogenic potential of various cobalt compounds perhaps has been demonstrated best in injection studies in experimental animals (reviewed in IARC, 1991), and both insoluble and soluble forms have been shown to produce injection-site neoplasms.
The present demonstration of alveolar/bronchiolar neoplasms in rats and mice exposed to water-soluble cobalt sulfate by inhalation confirms the findings of the injection studies and suggests that cobalt is inherently carcinogenic. These findings also lend credence to the epidemiological investigations (Mur FIG. 10 . Growth curves for mice exposed to cobalt sulfate by inhalation for 2 years.
et al. (1987) , Hogstedt and Alexandersson (1990), and Lasfargues et al. (1994) ), which reported increased risks for lung cancer among workers producing cobalt and exposed to cobalt in a hard metal industry. Cobalt concentrations in the urine of workers in the Italian hard-metal industry were found to be as high as 0.21 g/mL at the end of the work shift (Sabbioni et al., 1994) . Ichikawa et al. (1985) reported higher concentrations (0.39 g/mL) in Japanese workers. In 13-week inhalation studies (NTP, 1991) , average urinary cobalt concentrations in rats exposed to 0.3, 1.0, and 3.0 mg/m 3 , respectively, were 0.14, 0.32, and 1.77 g/mL. If urinary cobalt concentrations roughly approximate relative inhalation exposures to cobalt, then the results from the current 2-year rat and mouse studies appear similar to occupational exposures and suggest that humans and rodents may be similarly sensitive to cobalt carcinogenesis.
The mechanisms of cobalt-induced carcinogenesis are not well understood. The genotoxicity of cobalt compounds has been established in a variety of eukaryotic test systems (reviewed in IARC, 1991), and cobalt has been shown under certain conditions to catalyze the production of oxygen-based free radicals, which may underlie some of the observed adverse genetic events (Kasprzak et al., 1994; Shi et al., 1993) . The observation from these cobalt sulfate studies of a larger than usual number of G to T transversions in codon 12 of mouse lung neoplasms carrying a mutated K-ras gene (NTP, 1998) is also consistent with oxidative injury. Similar increases in G to T transversions were seen in lung neoplasms from mice ex- (Sills et al., 1995) . Porter et al. (1997) showed that cobalt acetate was capable of inhibiting cellular 8-oxodGTPases which function to remove 8-oxo-dGTP from the nucleotide pool. This may represent a secondary mechanism whereby cobalt may exert a pro-oxidant pattern of injury without involving direct redox cycling of the metal or metal complex.
The potential contribution of the sulfate moiety to the carcinogenic response deserves note, in that exposures of humans to concentrated inorganic acid mists cause respiratory tract neoplasms, primarily in the larynx (IARC, 1992) . There are no experimental animal carcinogenicity studies with sulfuric acid mists per se (IARC, 1992) , but nickel sulfate hexahydrate was studied by inhalation (NTP, 1996c) . In this instance, there was no evidence of carcinogenicity of nickel sulfate hexahydrate (at concentrations as high as 0.5 mg/m 3 for rats or 1 mg/m 3 for mice) to the respiratory tract or other tissues, despite the fact that other nickel salts are carcinogenic. Thus, there is at least this suggestion that the sulfate moiety alone was not responsible for and did not contribute to the carcinogenic response.
There was evidence in male mice of an infection with Helicobacter hepaticus. The potential for this infection to compromise the findings of 2-year cancer studies has been examined in detail (Hailey et al., 1998) . This analysis suggested that hepatocellular neoplasms and hemangiosarcomas occurring in the liver are influenced by this infection. Because of this potential confounder, the increase in hemangiosarcomas in male mice exposed to 1.0 mg/m 3 cannot be attributed with certainty to cobalt sulfate. There is no reason to question the association of the pulmonary tumor response in the infected male mice with cobalt sulfate.
In summary, these studies indicate that exposure to cobalt sulfate by inhalation resulted in increased incidence of alveolar/bronchiolar neoplasms in both sexes of rats and mice. Adrenal pheochromocytomas were increased in female rats, and possibly in male rats. Exposure to cobalt sulfate caused a spectrum of inflammatory, fibrotic, and proliferative lesions in the respiratory tracts of male and female rats and mice. 
